＜3628＞ Data HR 630 -106

Year-to-date low. The operating profit and loss forecast for the fiscal year ending 24/6 has been revised downward from conventional profit and loss tons to a deficit of 900 million yen (deficit of 498 million yen in the previous fiscal year results). This is because the progress of orders for data health-related services etc. has been delayed, such as taking longer than expected, and sales are expected to fall below previous expectations. Continuing investment for medium-term business expansion also became important. The cumulative operating profit and loss for the 3rd quarter (23/7/24 to 3/24) landed at a deficit of 422 million yen (deficit of 369 million yen in the same period last year).

＜4425＞ Kudan 1785 +77

A significant increase of 3 days. It has been announced that Kudan's proprietary technology will be mounted on the four-legged walking robot “Bex” of Kawasaki Heavy Industries ＜7012＞. At the “2024 IEEE International Conference on Robotics and Automation” to be held on 13-17, Kudan's development kit for robots will be mounted on the four-legged walking robot exhibited at the Kawasaki Heavy Industries exhibition booth, and artificial perception technology based on a unique SLAM algorithm will grasp the surrounding environment, three-dimensional mapping, and position positioning in real time.

＜5255＞ Monster Lab 368 +15

The price has been high since the beginning of the year. It has been announced that a new strategic business alliance has started with US eVISIT, which provides telemedicine solutions. It is an important step in integrating comprehensive telemedicine solutions with advanced digital transformation strategies. Also, a new strategic business alliance will be formed with Journee, which handles immersive software development in the United Arab Emirates (UAE). It is said that both companies will jointly set cooperation targets in the market and plan market introduction (GTM) of products.

＜7069＞ Cyber Buzz 2058 -500

Stop cheap. The operating profit and loss forecast for the fiscal year ending 24/9 has been revised downward from the previous surplus of 470 million yen to a deficit of 1,745 billion yen (surplus of 391 million yen in the previous fiscal year). Although sales were revised upward from 6.720 billion yen to 7.420 billion yen (same 5.757 billion yen) in response to strong sales of influencer services and internet advertisement sales, it is expected that they will fall into the red since loan provision amounts of 2,215 billion yen due to the risk of inability to collect or delays in collection of claims were recorded as sales and administration expenses.

＜6026＞ GMOTECH 6700 +1000

The stop is high. The operating profit forecast for the fiscal year ending 24/12 has been revised upward from the previous 800 million yen to 1,040 million yen (previous fiscal year results 566 million yen). The customer attraction support business, centered on affiliate services, continues to grow, and the SEM service and real estate tech business are also doing well. Cost reduction through promotion of efficiency is also expected to boost profits. At the same time, the year-end dividend forecast has been increased and revised from the previous 228.44 yen to 293.06 yen (previous year-end results 184.48 yen).

＜6092＞ Enbio HD 610 +16

Significant backlash. The operating profit forecast for the fiscal year ending 24/3 has been revised upward from the previous 625 million yen to 815 million yen (previous fiscal year results 1,357 billion yen). Although the sales forecast was revised downward from 9.740 billion yen to 9.575 billion yen (same 8.120 billion yen) due to delays in the completion of some construction work in the soil contamination countermeasures business, operating profit is expected to rise due to improvements in profit margins in the same business and the brownfield utilization business. The fact that stock price levels have been rounded up, such as above the 200-day moving average, also seems to be boosting buying.